patent/NZ-709067-A

http://rdf.ncbi.nlm.nih.gov/pubchem/patent/NZ-709067-A

Outgoing Links

Predicate	Object
assignee	http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_cf32b60391b469c41e86c353437f5751
classificationCPCAdditional	http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2300-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-1652 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-4866 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-4858 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-106 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-1623 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-172 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-158 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-156
classificationCPCInventive	http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2086 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2054 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2059 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4748 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2018 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-444 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6883 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-44 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-439
classificationIPCInventive	http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-44 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4748 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-28
filingDate	2013-12-09-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor	http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_24dd23bd922de74e38dc6cbfbc70f5a3 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5eaa511047c24ad091fff13eca722485 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cbcc55ee47beaeb222df8ecc06ca801d http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8cc7d476ae0ae5f733a959b041989992 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0c154a5890245cbb7077e196fb9468b4 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_db3d03f956893703605fe35112333c2f http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_889b02f374e2c28aaf476494bb605b13 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4dda41751203f350cc97b8155591b2af http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4b1bdc64cda39587c481f4ee2fcf4fc3
publicationDate	2016-08-26-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber	NZ-709067-A
titleOfInvention	Biomarker predictive of responsiveness to alpha 7 nicotinic acetylcholine receptor activator treatment
abstract	The invention provides methods for predicting therapeutic responsiveness of a subject suffering from cognitive impairments or dysfunctions, psychotic and/or neurodegenerative disorders to treatment with (R)-3-(6-p-tolyl-pyridin-3-yloxy)-1-aza-bicyclo[2.2.2]octane, wherein responsiveness is predicted on the basis of the individual having at least one indicative SNP of the human cytochrome P450 1A2 (CYP1A2).
priorityDate	2012-12-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type	http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID50914822 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414452795

Total number of triples: 46.